[Angioedema of the tongue and oropharynx after treatment with sublingual captopril].
Angioedema of the tongue and oropharynx is a rare and potentially life threatening adverse reaction related to the use of angiotensin converting enzyme inhibitors. We report a case of a patient who suffered angioedema of the tongue following sub-lingual Captopril treatment and discuss the prevalence, prevention and treatment of this adverse event. This case report is an addition to a limited number of similar cases and denotes the severity of this phenomenon and the need to be aware of its existence.
Arzi
H
H
Medical School, Hebrew University, Jerusalem.
Ben-Dror
G
G
Mijiritzky
Y
Y
D000286:Administration, Sublingual; D000799:Angioedema / Q000139:chemically induced*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D002216:Captopril / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009960:Oropharynx; D010608:Pharyngeal Diseases / Q000139:chemically induced*; D014060:Tongue Diseases / Q000139:chemically induced*
D000806:Angiotensin-Converting Enzyme Inhibitors; D002216:Captopril